Table of Content

Open Access iconOpen Access

REVIEW

IL-37: a new anti-inflammatory cytokine of the IL-1 family

Diana Boraschi1, Davide Lucchesi1, Stefan Hainzl2, Maria Leitner2, Elisabeth Maier2, Doris Mangelberger2, Gertie J. Oostingh2, Tobias Pfaller2, Claudia Pixner2, Gernot Posselt2, Paola Italiani1, Marcel F. Nold3,4, Claudia A. Nold-Petry3,4, Philip Bufler5, Charles A. Dinarello3

1 Laboratory of Innate Immunity and Cytokines, Institute of Biomedical Technologies, National Research Council, I-56124 Pisa, Italy
2 Department of Molecular Biology, University of Salzburg, Austria
3 Department of Medicine, University of Colorado Denver, Aurora, CO, USA
4 The Ritchie Centre, Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia
5 Children’s Hospital, Ludwig-Maximilians University, Munich, Germany

European Cytokine Network 2011, 22(3), 127-47. https://doi.org/10.1684/ecn.2011.0288

Abstract

The IL-1 family of cytokines encompasses eleven proteins that each share a similar β-barrel structure and bind to Ig-like receptors. Some of the IL-1-like cytokines have been well characterised, and play key roles in the development and regulation of inflammation. Indeed, IL-1α (IL-1F1), IL-1β (IL-1F2), and IL-18 (IL-1F4) are well-known inflammatory cytokines active in the initiation of the inflammatory reaction and in driving Th1 and Th17 inflammatory responses. In contrast, IL-1 receptor antagonist (IL-1Ra, IL-1F3) and the receptor antagonist binding to IL-1Rrp2 (IL-36Ra, IL-1F5) reduce inflammation by blocking the binding of the agonist receptor ligands. In the case of IL-37 (IL-1F7), of which five different splice variants have been described, less is known of its function, and identification of the components of a heterodimeric receptor complex remains unclear. Some studies suggest that IL-37 binds to the α chain of the IL-18 receptor in a non-competitive fashion, and this may explain some of the disparate biological effects that have been reported for mice deficient in the IL-18R. The biological properties of IL-37 are mainly those of down-regulating inflammation, as assessed in models where human IL-37 is expressed in mice. In this review, an overview of the role of IL-37 in the regulation of inflammation is presented. The finding that IL-37 also locates to the nucleus, as do IL-1α and IL-33, for receptor-independent organ/tissue-specific regulation of inflammation is also reviewed.

Keywords

IL-37, IL-1F7, IL-1 cytokines, inflammation, IL-18, IL-18BP

Cite This Article

APA Style
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E. et al. (2011). IL-37: a new anti-inflammatory cytokine of the IL-1 family. European Cytokine Network, 22(3), 127–47. https://doi.org/10.1684/ecn.2011.0288
Vancouver Style
Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Network. 2011;22(3):127–47. https://doi.org/10.1684/ecn.2011.0288
IEEE Style
D. Boraschi et al., “IL-37: a new anti-inflammatory cytokine of the IL-1 family,” Eur. Cytokine Network, vol. 22, no. 3, pp. 127–47, 2011. https://doi.org/10.1684/ecn.2011.0288



cc Copyright © 2011 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 24

    View

  • 24

    Download

  • 0

    Like

Share Link